Philip Vanek
Chief Tech/Sci/R&D Officer at Gamma Biosciences
Philip Vanek active positions
| Companies | Position | Start | End |
|---|---|---|---|
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Director/Board Member | 15/07/2015 | - |
Gamma Biosciences
 Gamma Biosciences Packaged SoftwareTechnology Services Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 31/03/2020 | - |
Career history of Philip Vanek
Statistics
International
| Canada | 2 |
| United States | 2 |
Operational
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Health Technology |
Gamma Biosciences
Gamma Biosciences Packaged SoftwareTechnology Services Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA. | Technology Services |
- Stock Market
- Insiders
- Philip Vanek
- Experience
